Archives for Uncategorized

Plaintiff attorneys cite new medical evidence in motion for Xarelto federal bellwether case retrial

New Data Could Add $1.5 Billion To Sales Of Johnson & Johnson Blood Thinner Plaintiff attorneys from the recently decided trio of bellwether cases in the federal multi-district litigation surrounding blood thinner drug Xarelto have filed motions seeking retrials, believing newly released medical evidence contradicted the cases’ courtroom testimony and would have swayed the jury to find for their clients. In August, a seven-person jury from the U.S. District Court for the Southern District of Mississippi decided that Bayer and Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, were not responsible for the internal bleeding and anemia suffered by Dora
Read More

New Data Could Add $1.5 Billion To Sales Of Johnson & Johnson Blood Thinner

New Data Could Add $1.5 Billion To Sales Of Johnson & Johnson Blood Thinner New data could lead doctors to use Johnson & Johnson and Bayer’s blood thinner Xarelto to prevent heart attacks in some patients, leading to a significant sales boost. In a note to investors earlier this month, Credit Suisse analyst Divan Vamil predicted that a successful result could increase sales of the drug by $1.5 billion in the U.S. alone. Well, the results are a success, although they come with the same trade-off as any use of a blood thinner: more bleeding. In results published in the
Read More

Behind the headlines: Does grapefruit interact with Xarelto (rivaroxaban)?

Behind the headlines: Does grapefruit interact with Xarelto (rivaroxaban)? The claim:   In a recent newspaper article (ref 1), it was stated that “grapefruit eaten in ordinary amounts can interact harmfully with some common prescription drugs”.  Among the drugs listed is the oral anticoagulant Xarelto® (rivaroxaban). Xarelto was approved by the FDA on November 2, 2012 for the treatment and prevention of deep vein thrombosis and pulmonary embolism.  The FDA-approved prescribing information makes no mention of a grapefruit/Xarelto interaction.  As Xarelto is a newly approved drug in which both patients and healthcare professionals are learning about its use, I wondered if the newspaper
Read More

Most Dangerous Drugs: Xarelto, Pradaxa and Other Blood Thinners

Most Dangerous Drugs: Xarelto, Pradaxa and Other Blood Thinners If asked what the most dangerous prescription drug was, what would you answer? Given the news about opioid addiction, a lot of people would likely answer something like OxyContin or fentanyl. 48.8% Nearly half of anticoagulant adverse events required a hospital stay. As it turns out, according to a recent report published by the Institute for Safe Medication Practices (ISMP) the prescription medications most likely to require an emergency room visit are anticoagulants – also known as blood thinners. These include drugs like Xarelto, Pradaxa, and warfarin, all of which use different biochemical interactions to prevent
Read More

Study Asserts Doctors Ignoring Contraindications When Prescribing Xarelto & Eliquis

Study Asserts Doctors Ignoring Contraindications When Prescribing Xarelto & Eliquis A recent study asserts that doctors are not following safety guidelines when prescribing anticoagulant medications like Xarelto and Eliquis. Both of these drugs are the subject of personal injury lawsuits that have been filed around the country. The study was published June 19, 2017, in the British Journal of General Practice. Researchers examined data from 645 general practices contributing to the Health Improvement Network, a large U.K. database of primary care records. Doctors Ignoring Contraindications for Anticoagulant Drugs Anticoagulant medications like Xarelto and Eliquis have been found to increase the
Read More

Jury Hands J&J, Bayer Win In 3rd Xarelto Bellwether

Jury Hands J&J, Bayer Win In 3rd Xarelto Bellwether The trial was the third win for Janssen and Bayer in a bellwether trial in Louisiana multidistrict litigation over claims they didn’t warn about the possibility of dangerous internal bleeding associated with the blood thinner. The trial was the third win for Janssen and Bayer in a bellwether trial in Louisiana multidistrict litigation over claims they didn’t warn about the possibility of dangerous internal bleeding associated with the blood thinner. The trial was presided over by a Louisiana federal judge but took place in Jackson, Mississippi. A fourth bellwether trial is
Read More

$417 Million Awarded in Suit Tying Johnson’s Baby Powder to Cancer

$417 Million Awarded in Suit Tying Johnson’s Baby Powder to Cancer In what may be the largest award so far in a lawsuit tying ovarian cancer to talcum powder, a Los Angeles jury on Monday ordered Johnson & Johnson to pay $417 million in damages to a medical receptionist who developed ovarian cancer after using the company’s trademark Johnson’s Baby Powder on her perineum for decades. Eva Echeverria, 63, of East Los Angeles is one of thousands of women who have sued the consumer products giant Johnson & Johnson claiming baby powder caused their disease, pointing to studies linking talc
Read More

How Xarelto Lawyers Scare People Out Of Taking Their Meds

How Xarelto Lawyers Scare People Out Of Taking Their Meds The television commercial begins simply: “This is a legal alert for the users of Xarelto.” Lawyers, the narrator says, are reviewing claims that the blood-thinning drug can cause “severe bleeding or hemorrhaging, stroke or even death.” If affected, viewers are advised to call a number on the screen. “You may have a case,” the speaker intones. In 2015, lawyers spent $128 million to air 365,000 ads like this, which seek plaintiffs for lawsuits against drug and medical-device manufactures. In the first six months of this year, that number jumped to
Read More

Some Lawyer Ads Can Scare You To Death

Some Lawyer Ads Can Scare You To Death Many doctors and pharmacists bemoan the omnipresent advertising for prescription drugs prompting viewers to “ask their doctor” about a product that may or may not be the best – or most economical – treatment for a patient’s condition. But a different kind of TV advertisement can create an even more dangerous outcome, in which patients whose doctors prescribed a medication stop taking it. Lawyers, especially those who specialize in class-action suits, have long used television spots to solicit clients. And fear is a particularly potent advertising tactic. So when an ad details
Read More

Xarelto Linked to Over 20,000 Injuries in 2016: ISMP Report

Xarelto Linked to Over 20,000 Injuries in 2016: ISMP Report As bellwether trials continue in the consolidated Xarelto Multidistrict litigation (“MDL”) pending in the U.S. District Court for the Eastern District of Louisiana, a new drug safety report highlights the dangerous side effects associated with the medication. Xarelto (rivaroxaban) is an anticoagulant drug that has been linked with serious bleeding concerns, including gastrointestinal bleeding and brain hemorrhaging. It was first released on the U.S. market in 2011. The new report was released by the Institute for Safe Medication Practices (ISMP), a nonprofit organization that educates the healthcare community and consumers
Read More